Celiac disease

Celiac Disease, also known as celiac sprue or gluten-sensitive enteropathy, causes damage to the small intestine in response to gluten consumption. Below are COVID news and research updates that specifically relate to Celiac Disease.

COVID-19 Does Not Increase Risk of Celiac Disease

Researchers in Sweden used 1.4 million health records to examine the rate of new Celiac disease diagnoses in those who had experienced a COVID-19 infection versus those who had not. Findings suggested that respiratory diseases do not increase the risk of developing Celiac disease the way gastrointestinal infections do.

Read More »

Can You Get Celiac Disease From a COVID-19 Infection?

A recent article explores the potential association between COVID-19 infection and the development of celiac disease. The researchers hypothesized that there might be an increased risk of developing celiac disease due to a COVID-19 infection potentially triggering an autoimmune response in genetically predisposed individuals or the COVID-19 infection disrupting the intestinal barrier function, altering the immune response and contributing to the development of celiac disease.

Read More »

Risk of Developing Autoimmune Disease Following COVID-19 Infection

A recent study exploring the association between COVID-19 infection and the risk of developing autoimmune diseases was conducted by a team of researchers from various institutions in Taiwan using data from the “TriNetX database, which holds the largest global COVID-19 dataset.” The team analyzed the medical record data of 3.8 million patients in the U.S., of which 888,460 had received a COVID-19 diagnosis (polymerase chain reaction–confirmed) between January 1, 2020, and December 31, 2021.

Read More »

Autoimmunity & COVID: Are You More at Risk?

Researchers in Italy studied whether autoimmunity increased the risk of SARS-CoV-2 infection in patients not taking immunosuppressive drugs. Researchers contacted 400 patients with the following autoimmune diseases: autoimmune gastritis, celiac disease, autoimmune thyroid disease (both Graves’ disease and Hashimoto’s thyroiditis), and Type 1 diabetes. Positive COVID-19 test results were reported in 33 patients. Only 3 of the 33 patients required hospitalization, while 8 were asymptomatic, and 22 had mild symptoms. No deaths were recorded.

Read More »